Objective: Investigation of the efficacy of ultraviolet (UV) A1 phototherapy on atopic eczema,
scleroderma, granuloma annulare, urticaria pigmentosa, prurigo nodularis, lichen sclerosus …

Background: The efficacy and safety of UVA1 (340–400 nm) phototherapy were established
by studies from European countries. Purpose: Evaluate experience with UVA1 phototherapy …

Background Ultraviolet (UV) radiation has been used for decades to treat a variety of skin
diseases. UVA1 was used initially as an effective treatment for acute exacerbated atopic …

During the last three decades, ultraviolet A1 (UVA1) phototherapy has emerged as a specific
phototherapeutic modality with distinct modes of action and some well established …

Ultraviolet radiation (UVR) phototherapy has been associated with both deleterious and
beneficial effects to patients with both localized and systemic skin disorders. Phototherapy is …

BACKGROUND: Atopic dermatitis (AD) is a genetically determined pruritic skin disease
affecting predominantly young people. The therapy of AD includes mainly corticosteroids …

Results After 15 treatments the" high dose" and" medium dose" groups showed a statistically
significant reduction of the SCORAD. No significant reduction of the SCORAD was observed …

Background: UVA1 (340-400 nm) therapy proved to be highly effective in patients with
severe atopic dermatitis. The optimal dose regarding therapeutic efficacy and possible side …

Background: Besides glucocorticosteroids, there is currently no known effective therapy for
patients with acute atopic dermatitis. Objective: The therapeutic effectiveness of high-dose …

Background: Several studies have demonstrated the efficacy of UVA1 (340-400 nm)
phototherapy for patients with severe atopic dermatitis. However, the optimum treatment …